U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
144721144721Long-term Extension Study of the SERAPHIN Study, to Assess the Safety and Tolerability of ACT 064992 in Patients With Symptomatic Pulmonary Arterial HypertensionActive, not recruitingNo Results AvailablePulmonary Arterial HypertensionDrug: ACT-064992https://ClinicalTrials.gov/show/NCT00667823
144722144722Study Evaluating The Efficacy And Safety Of Bapineuzumab In Alzheimer Disease PatientsTerminatedNo Results AvailableAlzheimer DiseaseDrug: bapineuzumab|Drug: bapineuzumab|Drug: placebohttps://ClinicalTrials.gov/show/NCT00667810
144723144723Costs & Outcomes of Hospitalization/Treatment With Levalbuterol & Albuterol in Asthma or Chronic Obstructive Pulmonary Disease (COPD) SubjectsCompletedNo Results AvailableAsthma|COPDDrug: levalbuterol HCl|Drug: albuterol Sulfatehttps://ClinicalTrials.gov/show/NCT00667797
144724144724Long Term Minor Sibling Donor Well-BeingTerminatedNo Results AvailableDisorder Related to Bone Marrow Transplantation|Blood Stem Cell Transplant Failure|Disturbance of Emotions Specific to Childhood and Adolescence|Transmission, Blood, Recipient/Donor|SiblingBehavioral: Questionnairehttps://ClinicalTrials.gov/show/NCT00667784
144725144725The Effect of Naltrexone on Alcohol Craving and on Brain Activity During Alcohol InfusionCompletedNo Results AvailableAlcohol Dependence|AlcoholismDrug: Naltrexonehttps://ClinicalTrials.gov/show/NCT00667771
144726144726Gonadotropin-Releasing Hormone (GnRH)-Antagonist Therapy in Rheumatoid ArthritisCompletedNo Results AvailableRheumatoid ArthritisDrug: Cetrorelix|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00667758
144727144727Effectiveness of Lithium Plus Optimized Medication in Treating People With Bipolar DisorderCompletedHas ResultsBipolar DisorderDrug: Lithium Carbonate|Drug: Optimized Treatment (OPT)https://ClinicalTrials.gov/show/NCT00667745
144728144728How Glargine Insulin, Oral Diabetes Medications and Exenatide May Improve Blood Sugar Control and Weight Gain in Type 2 DiabeticsCompletedHas ResultsType 2 DiabetesDrug: exenatide|Drug: placebohttps://ClinicalTrials.gov/show/NCT00667732
144729144729A Long Term Safety Study to Test the Combination of Aliskiren/ Amlodipine / Hydrochlorothiazide in Patients With Essential HypertensionCompletedNo Results AvailableEssential HypertensionDrug: aliskiren /amlodipine/hydrochlorothiazidehttps://ClinicalTrials.gov/show/NCT00667719
144730144730Laparoscopic Roux-en-Y Gastric Bypass Versus Laparoscopic Sleeve GastrectomyNot yet recruitingNo Results AvailableMorbid ObesityProcedure: laparoscopic operation Sleeve Gastrectomy|Procedure: laparoscopic operation Roux-en-Y Gastric bypasshttps://ClinicalTrials.gov/show/NCT00667706
144731144731Pentax Airway Scope (AWS) IntubationCompletedNo Results AvailableObesityDevice: Macintosh intubation|Device: Pentax AWShttps://ClinicalTrials.gov/show/NCT00667693
144732144732Transcranial Direct Current Stimulation (tDCS) in Treatment-resistant DepressionCompletedNo Results AvailableTherapy Resistant Major DepressionDevice: Transcranial direct current stimulation (tDCS) - Eldith DC-Stimulatorhttps://ClinicalTrials.gov/show/NCT00667680
144733144733Effects of Whole Body Vibration on Postmenopausal Risk-factors in Elderly WomenTerminatedNo Results AvailablePostmenopausalDevice: vertical vibration device (Vibrafit whole body vibration platform)|Device: side alternating vibration device (Board 3000 whole body vibration platform)|Behavioral: stretching and wellness (control group)https://ClinicalTrials.gov/show/NCT00667667
144734144734Safety and Tolerability of 4975 in the Treatment of Moderate to Severe Knee Pain Due to Osteoarthritis (OA)CompletedNo Results AvailableOsteoarthritis of the KneeDrug: 4975https://ClinicalTrials.gov/show/NCT00667654
144735144735Paclitaxel and Bortezomib in Treating Patients With Metastatic or Unresectable Malignant Solid TumorsCompletedNo Results AvailableBreast Cancer|Colorectal Cancer|Head and Neck Cancer|Lung Cancer|Melanoma (Skin)|Ovarian Cancer|Pancreatic Cancer|Prostate Cancer|Unspecified Adult Solid Tumor, Protocol SpecificDrug: bortezomib|Drug: paclitaxelhttps://ClinicalTrials.gov/show/NCT00667641
144736144736Phase 2 Study of TAC-101 Combined With Transcatheter Arterial Chemoembolization (TACE) Versus TACE Alone in Japanese Patients With Advanced Hepatocellular CarcinomaTerminatedNo Results AvailableAdvanced Hepatocellular CarcinomaDrug: TAC-101|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00667628
144737144737Trial of Vorinostat in Combination With Cyclophosphamide, Etoposide, Prednisone and Rituximab for Elderly Patients With Relapsed Diffuse Large B-Cell Lymphoma (DLBCL)Active, not recruitingNo Results AvailableHodgkin's Disease|LymphomaDrug: rituximab, cyclophosphamide, etoposide, prednisone, vorinostat and QOL questionnaire, peg-filgrastim or filgrastimhttps://ClinicalTrials.gov/show/NCT00667615
144738144738Safety and Immunogenicity Evaluation After One or Two Doses of Novartis Meningococcal ACWY Conjugate Vaccine in Healthy Infants and ToddlersCompletedHas ResultsMeningococcal MeningitisBiological: MenACWY-CRM197 (two doses)|Biological: MenC|Biological: PCV7|Biological: DTPa-IPV-HepB-Hib|Biological: MenACWY-CRM197 (one dose)https://ClinicalTrials.gov/show/NCT00667602
144739144739Sorafenib-induced Hand- Foot Skin Reaction TreatmentTerminatedHas ResultsHand-foot Skin Reaction|RashDrug: urea 40% cream|Drug: fluocinonide 0.05% cream|Drug: tazarotene 0.1% cream|Drug: bland emollient cream (Udderly smooth® Udder Cream)https://ClinicalTrials.gov/show/NCT00667589
144740144740Dose-response Study of Paricalcitol Injection in Chronic Kidney Disease Patients Receiving HemodialysisCompletedHas ResultsChronic Kidney Disease on Hemodialysis|Secondary HyperparathyroidismDrug: Maxacalcitol|Drug: Paricalcitolhttps://ClinicalTrials.gov/show/NCT00667576
144741144741Vaccine Therapy in Preventing HPV in HIV-Positive Women in IndiaCompletedHas ResultsCervical Cancer|Nonneoplastic Condition|Precancerous ConditionBiological: quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine|Genetic: DNA analysis|Genetic: polymerase chain reaction|Other: cytology specimen collection procedure|Procedure: colposcopic biopsyhttps://ClinicalTrials.gov/show/NCT00667563
144742144742Lower Urinary Tract and Sexual Function in Women Following Surgery for Colorectal DisordersCompletedNo Results AvailableLower Urinary Tract Symptoms|Colorectal Disordershttps://ClinicalTrials.gov/show/NCT00667550
144743144743Radium-223 in Patients With Hormone Refractory Prostate Cancer (HRPC) and Skeletal MetastasesCompletedNo Results AvailableHormone Refractory Prostate Cancer|Bone MetastasesDrug: Alpharadin TM (Radium-223)https://ClinicalTrials.gov/show/NCT00667537
144744144744Eosinophilic Esophagitis: Influence of Dilation on Dysphagia and InflammationCompletedNo Results AvailableEosinophilic Esophagitis|Esophageal Stenosis|Esophageal Dilation|Esophageal Dilatationhttps://ClinicalTrials.gov/show/NCT00667524
144745144745Comparison of Nocturnal Hemodialysis (NHD) and Short Daily Hemodialysis (DHD) With the NxStage® System One™CompletedHas ResultsKidney Failure, Chronic|End-Stage Renal DiseaseDevice: NxStage System Onehttps://ClinicalTrials.gov/show/NCT00667511
144746144746Metabolic Effect of Metformin in Obese Insulin Resistant Adolescents With Normal Glucose ToleranceCompletedNo Results AvailablePediatric Obesity|Insulin Resistance|HyperinsulinemiaDrug: Metformin|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00667498
144747144747Rapamycin Plus Bevacizumab in Advanced CancersCompletedNo Results AvailableAdvanced Cancer|Metastatic CancerDrug: Rapamycin (liquid)|Drug: Bevacizumab|Drug: Rapamycin (Tablets)https://ClinicalTrials.gov/show/NCT00667485
144748144748Combined Pulsed Dye Laser and Topical Ranibizumab for Treatment of Port Wine Stain BirthmarksWithdrawnNo Results AvailablePort-Wine StainDrug: Ranibizumab|Device: Pulsed Dye Laserhttps://ClinicalTrials.gov/show/NCT00667472
144749144749Study of Safety & Effectiveness of PRESTIGE® LP Cervical Disc vs. Anterior Cervical Fusion in Cervical DDDCompletedHas ResultsCervical Degenerative Disc DiseaseDevice: PRESTIGE® LP Cervical Disc|Device: ATLANTIS Anterior Cervical Platehttps://ClinicalTrials.gov/show/NCT00667459
144750144750Safety Extension Study Of Leuprolide Acetate (Lupron Depot) In The Treatment Of Central Precocious PubertyCompletedHas ResultsPrecocious|Leuprolide Acetate|Luteinizing Hormone (LH)|Gonadotrophin-releasing Hormone Agonist (GnRHa)|Tanner Staging|Depot Formulation|Suppression of LH|Central Precocious Puberty (CPP)|Gonadotrophin-releasing Hormone (GnRH)|Lupron|GnRH Analog|PediatricsDrug: Leuprolide Acetate 3 Month Depothttps://ClinicalTrials.gov/show/NCT00667446

* Görseller ve İçerik tekif hakkına sahip olabilir